Talon Therapeutics' leukemia drug granted accelerated approval by the FDA
06:59 EDT 16 Aug 2012 | Avakado
Talon Therapeutics’ leukemia drug Marqibo (vinCRIStine sulfate LIPOSOME injection) has received accelerated approval from the FDA for the treatment of adult patients with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) in..
Original Article: Talon Therapeutics' leukemia drug granted accelerated approval by the FDA
More From BioPortfolio on "Talon Therapeutics' leukemia drug granted accelerated approval by the FDA"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
